Steppingstone Inc. Projects
Medication-Assisted Treatment
About
Medication-Assisted Treatment
Also known as MAT, medication-assisted treatment involves treating those who have addictions by administering medication that curtails both cravings and withdrawal symptoms. When combined with therapy, MAT significantly increases the odds that SOAR consumers will successfully overcome their opioid addiction and experience long-term recovery and other positive outcomes. We offer Buprenorphine and Naloxone to treat opioid use disorders.
Steppingstone’s Medication-Assisted Treatment Program, offered through Project SOAR (Supporting Opioid Addiction Recovery), offers a consumer-centered approach to Medication-Assisted Treatment for individuals with opioid use disorders. In addition to MAT, we deliver effective therapy to consumers with other substance use and mental health disorders by leveraging individualized evidence–based therapies. A focused clinical assessment drives the development of an individualized treatment plan which may include clinical and supportive therapies, medical and mental health care as appropriate, and medication management as required.
SOAR’s approach ensures consumers get precisely the best treatment at the right time, thus maximizing their chances of recovery.
In conjunction with MAT, psychosocial treatment will be provided to participants through a variety of approaches including social skills training, individual, group, and couples counseling, cognitive behavioral therapy, motivational interviewing, and family therapy.
Research indicates that MAT
- Significantly increases a consumer’s adherence to treatment
- Reduces illicit opioid and other drug use
- Reduces criminal behaviors
- Empowers individuals to move forward in their lives and
experience other positive outcomes such as steady employment and housing stability
MAT Services Include:
- Substance use evaluations
- Mental health evaluation
- Medication Assisted Treatment (MAT) including naltrexone (oral and Vivitrol), buprenorphine/naloxone and buprenorphine mono-product
- Psychiatric services including evaluation and medication management
- Individual counseling
- Group therapy
- Family education
- Relapse prevention services
- Urine screening and breath analysis
- Trauma treatment
- Discharge and aftercare planning
Admission Criteria
- 18 years of age or older
- Have an opioid use disorder
